SHA:603229 Revenue

Zhejiang Ausun Pharmaceutical had revenue of 306.64M CNY in the quarter ending March 31, 2025, with 1.90% growth. This brings the company's revenue in the last twelve months to 801.01M, down -6.33% year-over-year. In the year 2024, Zhejiang Ausun Pharmaceutical had annual revenue of 795.29M, down -2.63%.

Revenue (ttm)

801.01M

Revenue Growth

-6.33%

P/S Ratio

9.49

Revenue / Employee

657.10K

Employees

1,219

Market Cap

7.60B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	795.29M	-21.48M	-2.63%
Dec 31, 2023	816.77M	52.22M	6.83%
Dec 31, 2022	764.55M	194.85M	34.20%
Dec 31, 2021	569.70M	160.45M	39.21%
Dec 31, 2020	409.25M	101.33M	32.91%
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro
Dec 31, 2015	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Jiangsu Hengrui Medicine	29.19B
Shenzhen Mindray Bio-Medical Electronics	35.59B
WuXi AppTec	39.59B
Sichuan Biokin Pharmaceutical	5.82B
Zhangzhou Pientzehuang Pharmaceutical.,	10.76B
Aier Eye Hospital Group	21.81B
Shanghai United Imaging Healthcare	10.43B
Yunnan Baiyao Group Co.,Ltd	40.10B

Revenue Rankings